Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
102242 trials found · Page 164 of 5113
-
Engineered immune cells target abdominal tumors in new cancer trial
Disease control Recruiting nowTo find the highest dose of NK cells that can be given by vein and intraperitoneally (given directly into the abdominal cavity) in combination with cetuximab to patients with colorectal cancer that has spread to the peritoneum.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 10, 2026 01:53 UTC
-
New hope for kids with bleeding disorder: drug trial launches
Disease control Not yet recruitingThe purpose of this study is to evaluate efficacy and of safety QL0911 in the treatment of thrombocytopenia in pediatric patients with previously treated chronic ITP.
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
Ambulance steroid shot could cut heart attack deaths
Disease control Recruiting nowBACKGROUND Myocardial reperfusion with the use of primary percutaneous coronary intervention (PCI) including stent implantation is the most efficacious treatment for patients with (STEMI) and improves prognosis significantly. Due to continuous improvements in the treatment, the m…
Phase: PHASE3 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 10, 2026 01:53 UTC
-
New hope for tough esophageal cancer: phase 3 trial launches
Disease control Recruiting nowThis study is designed to assess the efficacy and safety of QLC5508 in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) who have experienced disease progression following treatment with a platinum-based systemic therapy and an immune che…
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
Simple vitamins may shield kidneys from chemo damage, new study hopes
Prevention Not yet recruitingCisplatin is a widely used chemotherapy drug for many solid tumors (e.g., lung, bladder, ovarian, head and neck cancers). Despite its efficacy, its clinical use is limited by severe side effects, mainly nephrotoxicity, which occurs in \~30% of patients after treatment. Once insid…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Prevention
Last updated Jun 08, 2026 13:13 UTC
-
New drug aims to preserve lung function in autoimmune patients
Disease control Not yet recruitingInterstitial lung disease (ILD) is a common pulmonary manifestation in chronic tissue diseases (CTD), significantly affecting patient's prognosis. The main purpose of this study is to evaluate the efficacy of telitacicept compared with placebo in slowing down the decline in lung…
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
New 4-Pronged attack shows promise against tough lung cancer
Disease control Not yet recruitingThis is a single-arm, single-center, exploratory clinical study conducted at Shanghai Pulmonary Hospital, Tongji University. The study evaluates the effectiveness and safety of first-line treatment with benmelstobart (an immunotherapy), anlotinib (an anti-angiogenic drug), platin…
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New cocktail of drugs and radiation shows promise for tough lung cancer
Disease control Not yet recruitingThis is a single-center, single-arm, exploratory clinical study conducted at Shanghai Pulmonary Hospital, Tongji University. It aims to evaluate the efficacy and safety of first-line treatment with benmelstobart plus anlotinib and chemotherapy (carboplatin/cisplatin plus etoposid…
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
Plasma-Powered gel could revolutionize chronic wound healing
Disease control Recruiting nowThe goal of this randomized controlled trial is to evaluate the efficacy and safety of a novel hydrogel made of Carbopol® 940 functionalized with Plasma-Activated Water (PAW) in patients with chronic wounds (diabetic foot ulcers, pressure injuries, dehiscent wounds, arterial and …
Phase: NA • Sponsor: Benjamín Gonzalo Rodríguez Méndez • Aim: Disease control
Last updated May 29, 2026 14:15 UTC
-
New hope for liver cancer patients when first-line therapy fails
Disease control Not yet recruitingThis prospective, single-arm, multicenter Phase II clinical trial aims to evaluate the efficacy and safety of Benmelstobart plus anlotinib combined with SBRT in patients with oligometastatic hepatocellular carcinoma who have failed first-line targeted therapy. Key study questions…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis is a multicenter, phase III, randomized controlled trial. Eligible patients with pMMR/MSS locally advanced rectal cancer will be randomized in a 1:1 ratio to either the experimental group or the control group using stratified randomization, with mesorectal fascia (MRF) statu…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
New drug combo aims to cut relapse in tough myeloma cases
Disease control Not yet recruitingTo explore the efficacy and safety of thiotepa combined with melphalan for ASCT conditioning in patients with multiple myeloma who did not acheive CR with or without extramedullary inflitration before transplantation. After screening and enrollment, the patients were randomly di…
Phase: NA • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated May 29, 2026 14:17 UTC
-
Can a hospital intervention stop the cycle of gun violence?
Prevention Recruiting nowThe present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.
Phase: NA • Sponsor: University of Arkansas • Aim: Prevention
Last updated Jun 08, 2026 13:04 UTC
-
New combo therapy aims to extend life in advanced lung cancer
Disease control Not yet recruitingThis study intends to carry out prospective, randomized controlled clinical trials in many centers across the country to compare the efficacy and safety of immunotherapy after standard first-line chemotherapy or immunotherapy combined with interventional bronchial artery chemoemb…
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
Your own stem cells could save your hip from collapse
Disease control Recruiting nowThe commercial decalcified bone scaffold combined with the patient's autologous bone marrow mesenchymal stem cells was used for in vitro culture to form tissue-engineered bone, and the effect of this tissue-engineered bone in early non-traumatic femoral head necrosis was explored…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
New dengue drug trial aims to knock out virus faster
Disease control Recruiting nowThis is a randomized, open-label adaptive platform trial aiming to screen the antiviral effectiveness of the experimental drug(s) in early dengue infection * Primary objectives: * To determine the antiviral effectiveness of the experimental drug(s) in early dengue infection …
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
Grow your own knee cartilage: stem cell breakthrough trial
Disease control Recruiting nowThe joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 03, 2026 12:02 UTC
-
AI and biomarkers could end surgical diagnosis for endometriosis
Diagnosis Not yet recruitingEndometriosis is a prevalent gynecological condition affecting approximately 10% of women of reproductive age worldwide. It presents with nonspecific but often severe symptoms, including chronic pelvic pain (in 70% of cases) and infertility (in up to 40% of cases), imposing signi…
Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Jun 08, 2026 13:11 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control Recruiting nowThis is a randomized controlled, phase II clinical study designed to explore the efficacy and safety of nimotuzumab combined with immunotherapy and chemotherapy as neoadjuvant treatment for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). The primary endpoint of…
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 03, 2026 12:07 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control ENROLLING_BY_INVITATIONThis is a multicenter, single-arm, phase II clinical study evaluating the efficacy and safety of neoadjuvant finotonlimab (anti-PD-1), cetuximab (anti-EGFR), and docetaxel in patients with resectable recurrent head and neck squamous cell carcinoma (HNSCC) who have progressed afte…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC